Atypical antipsychotics in children with pervasive developmental disorders.
The treatment of pervasive developmental disorders (PDDs) is a challenging task, which should include behavioral therapy modifications as well as pharmacologic therapy. There has been a lack of data on using medications in children with PDDs until recent years. Within the last 10 years, an increase in clinical research has attempted to provide efficacy and safety data to support the use of medications in children with PDDs. Double-blinded and open-label research of atypical antipsychotics has been of particular focus. Evidence shows that atypical antipsychotics (AAs) may be useful in treating certain symptoms associated with PDDs, such as aggression, irritability, and self-injurious behavior. This article reviews the literature regarding the use of AAs in children with PDDs. Of the AAs, risperidone has the largest amount of evidence with five published double-blinded, placebo-controlled trials and nine open-label trials. These risperidone trials have consistently shown improvements in aggression, irritability, self-injurious behavior, temper tantrums, and quickly changing moods associated with autistic disorder and other PDDs. Data for the other AAs are limited, but ziprasidone and aripiprazole appear to be promising treatment options. Based on clinical trials, olanzapine and quetiapine have shown minimal clinical benefit and a high incidence of weight gain and sedation. It should be noted that all AAs do have a risk of metabolic syndrome, and patients should be monitored appropriately while receiving these medications. Overall, AAs can be beneficial in alleviating behavioral symptoms, and should be considered an appropriate therapeutic option, as part of a comprehensive treatment strategy, for children with PDD.
Chavez
Benjamin
B
Rutgers, State University of New Jersey, Piscataway, New Jersey, USA. bchavez@rci.rutgers.edu
Chavez-Brown
Mapy
M
Sopko
Michael A
MA
Rey
Jose A
JA
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D002675:Child, Preschool; D015897:Comorbidity; D018849:Controlled Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism
D014150:Antipsychotic Agents; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine
J Autism Dev Disord. 2004 Apr;34(2):163-75
15162935
Schizophr Bull. 1982;8(2):320-32
6126001
Neuropsychology. 2006 Jan;20(1):21-9
16460219
J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):431-9
16601648
J Clin Psychiatry. 2005 Dec;66(12):1592-7
16401163
Am J Med Genet. 2001 May 8;105(4):381-6
11378854
Ann Pharmacother. 2006 May;40(5):909-16
16684811
Biol Psychiatry. 2007 Feb 15;61(4):545-50
16730335
Mol Interv. 2004 Apr;4(2):109-23
15087484
J Clin Psychiatry. 2000 Apr;61(4):252-60
10830145
J Clin Psychopharmacol. 2000 Apr;20(2):220-5
10770461
J Clin Psychiatry. 1994 Sep;55 Suppl B:27-9
7961567
J Child Psychol Psychiatry. 1987 Nov;28(6):885-900
3436995
J Pediatr. 1961 Mar;58:315-20
13747230
Child Dev. 1999 Jul-Aug;70(4):817-32
10446722
Neurol Clin. 2003 Nov;21(4):915-32, viii
14743656
Nat Genet. 2007 Jan;39(1):25-7
17173049
Child Care Health Dev. 2006 Sep;32(5):511-9
16919130
J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):685-93
9136504
J Child Adolesc Psychopharmacol. 2004 Fall;14(3):455-63
15650503
J Child Adolesc Psychopharmacol. 1999;9(2):99-107
10461820
J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):140-7
11837403
J Child Neurol. 2004 Mar;19(3):155-64
15119475
J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1137-44
16239862
J Autism Dev Disord. 2007 Feb;37(2):210-7
16865547
Science. 1999 May 14;284(5417):1155-8
10325223
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):541-8
17069543
Am J Ment Retard. 1997 Nov;102(3):238-49
9394133
J Child Neurol. 2006 Jun;21(6):450-5
16948927
Diabetes Care. 2004 Feb;27(2):596-601
14747245
J Pharmacol Exp Ther. 1988 Nov;247(2):661-70
2460616
Nat Neurosci. 2006 Oct;9(10):1218-20
17001340
Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):23-42, viii
10674189
J Child Adolesc Psychopharmacol. 1996 Fall;6(3):177-90
9231311
Am J Psychiatry. 1996 May;153(5):738
8615435
J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):720-8
16721322
Hum Mol Genet. 1997 Dec;6(13):2233-8
9361027
J Clin Psychopharmacol. 1999 Feb;19(1):37-44
9934941
J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):887-94
11501687
J Clin Psychiatry. 1994 Sep;55 Suppl B:47-52
7961573
Psychopharmacol Bull. 1997;33(1):155-9
9133768
Life Sci. 2000 Aug 25;67(14):1667-82
11021352
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):287-94
15319025
J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1513-6
12447040
J Clin Psychopharmacol. 2003 Feb;23 (1):87-91
12544379
J Am Acad Child Adolesc Psychiatry. 2002 Aug;41(8):921-7
12164181
Synapse. 1990;6(3):292-308
1700486
J Int Neuropsychol Soc. 2006 May;12(3):314-26
16903124
Arch Gen Psychiatry. 1996 Nov;53(11):1001-8
8911223
J Autism Dev Disord. 2006 Jul;36(5):697-704
16614791
Am J Med Genet. 2002 Apr 8;114(3):277-83
11920848
J Am Acad Child Adolesc Psychiatry. 2002 Nov;41(11):1380-3
12410082
J Child Adolesc Psychopharmacol. 2000 Summer;10(2):79-90
10933118
Am J Psychiatry. 2005 Jun;162(6):1142-8
15930063
Psychiatr Clin North Am. 1991 Mar;14(1):165-82
1675463
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):575-87
17069546
N Engl J Med. 2002 Aug 1;347(5):314-21
12151468
J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84
16379507
Am J Psychiatry. 2005 Jul;162(7):1361-9
15994720
J Clin Psychiatry. 1996;57 Suppl 11:4-11
8941166
Pediatrics. 2006 Jul;118(1):e139-50
16818529
J Clin Psychiatry. 2003 Nov;64(11):1362-9
14658952
J Clin Psychiatry. 2001 Jun;62(6):479-80
11465533
Behav Modif. 2002 Jan;26(1):49-68
11799654
J Clin Psychopharmacol. 2002 Oct;22(5):455-60
12352267
J Am Acad Child Adolesc Psychiatry. 1998 Apr;37(4):372-6
9549957
Am J Psychiatry. 2006 Dec;163(12):2148-56
17151167
J Autism Dev Disord. 1997 Jun;27(3):313-23
9229261
J Child Adolesc Psychopharmacol. 2001 Fall;11(3):229-38
11642473
Pediatrics. 2004 Nov;114(5):e634-41
15492353
J Autism Dev Disord. 2003 Oct;33(5):509-17
14594330